1. Home
  2. BWEN vs RLYB Comparison

BWEN vs RLYB Comparison

Compare BWEN & RLYB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Broadwind Inc.

BWEN

Broadwind Inc.

HOLD

Current Price

$3.96

Market Cap

105.5M

Sector

Industrials

ML Signal

HOLD

Logo Rallybio Corporation

RLYB

Rallybio Corporation

N/A

Current Price

$16.79

Market Cap

89.2M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
BWEN
RLYB
Founded
N/A
2018
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
105.5M
89.2M
IPO Year
2009
2021

Fundamental Metrics

Financial Performance
Metric
BWEN
RLYB
Price
$3.96
$16.79
Analyst Decision
Strong Buy
Analyst Count
1
0
Target Price
$6.00
N/A
AVG Volume (30 Days)
347.6K
11.5K
Earning Date
05-14-2026
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
360.00
N/A
EPS
N/A
6.16
Revenue
$146,785,000.00
$858,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$17.37
N/A
P/E Ratio
N/A
$2.75
Revenue Growth
N/A
43.00
52 Week Low
$1.88
$0.48
52 Week High
$5.70
$17.57

Technical Indicators

Market Signals
Indicator
BWEN
RLYB
Relative Strength Index (RSI) 39.42 59.20
Support Level $3.46 $16.51
Resistance Level $4.15 $17.32
Average True Range (ATR) 0.21 0.42
MACD -0.05 -0.01
Stochastic Oscillator 11.63 73.68

Price Performance

Historical Comparison
BWEN
RLYB

About BWEN Broadwind Inc.

Broadwind Inc is a precision manufacturer of structures, equipment, and components for clean technology and other specialized applications. The company provides technologically high-value products to customers with complex systems and stringent quality standards that operate in the energy, mining, and infrastructure sectors in the United States of America. Its capabilities include heavy fabrications, welding, metal rolling, coatings, gear cutting and shaping, gearbox manufacturing and repair, heat treatment, CNG decompression, precision machining, assembly, engineering, and packaging solutions, among others. The company operates in four reportable segments: Heavy Fabrications, which generates the maximum revenue, Gearing, Industrial Solutions, and Corporate.

About RLYB Rallybio Corporation

Rallybio Corp is a clinical-stage biotechnology company comprised of experienced biopharma industry leaders with extensive research, development, and rare disease expertise with a mission to develop and commercialize life-transforming therapies for patients with severe and rare diseases. The company's program, RLYB116, is a differentiated complement component 5 (C5) inhibitor with the potential to treat diseases of complement dysregulation. The Company manages its operations as a single segment for the purposes of allocating resources, assessing performance, and making operating decisions. Rallybio's pipeline also includes RLYB332, a preclinical long-acting matriptase-2 antibody for the treatment of diseases of iron overload.

Share on Social Networks: